Franklin Biotechnology Discovery Fund Class R6
FRBRX
NASDAQ
| Weiss Ratings | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton Investments | |||
| Manager/Tenure (Years) | Evan S. McCulloch (27), Akiva Felt (5) | |||
| Website | http://www.franklintempleton.com | |||
| Fund Information | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Franklin Biotechnology Discovery Fund Class R6 | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | May 01, 2013 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.60% | |||
| Asset Allocation | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 3.95% | |||
| Stock | 94.94% | |||
| U.S. Stock | 80.49% | |||
| Non-U.S. Stock | 14.45% | |||
| Bond | 0.92% | |||
| U.S. Bond | 0.92% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.19% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.23% | |||
| 30-Day Total Return | 0.61% | |||
| 60-Day Total Return | 3.40% | |||
| 90-Day Total Return | 1.53% | |||
| Year to Date Total Return | 1.81% | |||
| 1-Year Total Return | -3.40% | |||
| 2-Year Total Return | 28.63% | |||
| 3-Year Total Return | 21.64% | |||
| 5-Year Total Return | 46.89% | |||
| Price | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $131.61 | |||
| 1-Month Low NAV | $127.97 | |||
| 1-Month High NAV | $133.61 | |||
| 52-Week Low NAV | $125.53 | |||
| 52-Week Low NAV (Date) | Jan 14, 2025 | |||
| 52-Week High NAV | $162.76 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Beta / Standard Deviation | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.61 | |||
| Standard Deviation | 18.58 | |||
| Balance Sheet | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 780.67M | |||
| Operating Ratios | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.69% | |||
| Turnover Ratio | 35.87% | |||
| Performance | FRBRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 6.96% | |||
| Last Bear Market Total Return | -11.72% | |||
